Search for Clinical Trial Results

Sponsored By

Hereditary Hemorrhagic Telangiectasia - 25 Studies Found

Status Study
Recruiting Study Name: Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
Condition: Hereditary Hemorrhagic Telangiectasia
Date: 2010-07-07
Completed Study Name: Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia
Date: 2009-12-11
Interventions:
  • Drug: Tranexamic acid first, than placebo

Completed Study Name: Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Date: 2011-07-19
Interventions: Drug: Submucosal Bevacizumab 200 mg Bevacizumab, injected submucosally- 100 mg per nostril
Completed Study Name: Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Date: 2011-07-18
Interventions: Drug: Bevacizumab The bevacizumab will then be sprayed by the treating physician in the clinic, under di
Active, not recruiting Study Name: Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia
Condition:
  • Hereditary Hemorrhagic Telangiectasia
  • Epistaxis

Date: 2011-11-28
Interventions: Drug: Thalidomide Eligible patients will receive thalidomi
Completed Study Name: Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
Condition:
  • Epistaxis
  • Hereditary Hemorrhagic Telangiectasia

Date: 2011-07-01
Interventions: Drug: Sodium tetradecyl sulfate (sotradecol) 3% Sodium tetradecyl sulfate (STS) is mixed with air at a r
Withdrawn Study Name: Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition:
  • Hereditary Hemorrhagic Telangiectasia (HHT)
  • Nosebleeds
    • Date: 2011-07-29
    Interventions: Drug: Ranibizumab Patients will be treated with a total of 4 applications of ranibizumab in a fine mist
Withdrawn Study Name: Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study
Condition:
  • Hereditary Hemorrhagic Telangiectasia
  • Idiopathic Vascular Ectas
    Date: 2014-11-06
    Interventions: Drug: Pomalidomide Other Names:
    • Pomalyst
    • CC-4047
    • Imno
Completed Study Name: Study of the Natural History and Genotype-Phenotype Correlations of Hereditary Hemorrhagic Telangiectasia Patients
Condition: Hereditary Hemorrhagic Telangiectasia
Date: 2000-02-24
Terminated Study Name: Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Condition:
  • Hereditary Hemorrhagic Telangiectasia
  • Epistaxis

Date: 2014-04-01
Interventions:
  • Drug: Bevacizumab Other Name:

Next >>>